© 1996 British Society for Rheumatology
research-article |
POLYMYALGIA RHEUMATICA IS ASSOCIATED WITH BOTH HLA-DRB1*0401 and DRBl*0404
NW Regional Tissue Typing Laboratory, St Mary's Hospital Hathersage Road, Manchester
*Department of Rheumatology and Pathology, Blackpool Victoria Hospital Blackpool
ARC Epidemiology Research Unit, University of Manchester Oxford Road, Manchester
Correspondence to:
Correspondence to: W. Ollier, ARC Epidemiology Research Unit, Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PT.
The frequency of HLA-DRB1 alleles was determined in 68 Caucasoid patients with polymyalgia rheumatica (PMR) and 140 controls using polymerase chain reaction (PCR) sequence-specific oligonucleotide typing. In keeping with previous studies, an increased frequency of DRB1*04 was observed in patients [55.9% vs 35.0%, odds ratio (OR) 2.4, 95% confidence interval (CI) 1.3–4.4]. HLA-DRBl*0101 frequency was also increased in patients, although less confidence could be placed on this association (19.1% vs 14.3%, OR 1.4,95% CI 0.6–3.3). HLA-DRB1*O4 subtyping indicated that the frequencies of both DRB1*0401 (38.2% vs 22.1%, OR 2.2, 95% CI 1.0–4.3) and DRB1*0404 (16.2% vs 5.0%, OR 3.7, 95% CI 1.2–11.1) were specifically raised. An increased frequency of the RA shared epitope (QKRAA/QRRAA) was also observed in this group (75.0% vs 44.2%, OR 3.8, 95% CI 1.9–7.6). When the analysis was restricted to only DRB1*04-negative patients and controls, the frequencies of DRB1*0301, *11 and *08 were marginally raised. However, no obvious relationship appeared to exist between PMR susceptibility and DRB1 alleles carrying the DYF conserved epitope in the second hypervariable region. Autoantibodies to thyroid antigens were present in 23% of patients. An increased frequency of DRBl*0301 was observed in patients with thyroid microsomal antibodies compared to those without (54.5% vs 24.6%, OR 3.7, 95% CI 0.8–17.0). This increase was not observed in patients with thyroglobulin autoantibodies. These data indicate that both DRB 1*0401 and *0404 are associated with PMR, and that this may extend to include DRB1*0101. The immunogenetic profile of susceptibility markers in this condition appears to be similar to that in rheumatoid arthritis.
KEY WORDS: Polymyalgia rheumatica, HLA-DR4, Thyroid antibodies
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Salvarani, F. Cantini, L. Boiardi, and G. G. Hunder Polymyalgia Rheumatica and Giant-Cell Arteritis N. Engl. J. Med., July 25, 2002; 347(4): 261 - 271. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Griffiths, R. D. Situnayake, B. Clark, A. Tennant, M. Salmon, and P. Emery Racial origin and its effect on disease expression and HLA-DRB1 types in patients with rheumatoid arthritis: a matched cross-sectional study Rheumatology, August 1, 2000; 39(8): 857 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Salvarani, L. Boiardi, V. Mantovani, A. Ranzi, F. Cantini, I. Olivieri, M. Bragliani, E. Collina, and P. Macchioni HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity Ann Rheum Dis, May 1, 1999; 58(5): 303 - 308. [Abstract] [Full Text]
|
|
|
|
|
|
E TOUSSIROT, S BERTHIER, D WENDLING, and P TIBERGHIEN Lack of association between HLA DRB1* alleles and RS3PE syndrome Ann Rheum Dis, July 1, 1998; 57(7): 442 - 442. [Full Text]
|
|
|
|
|
|
M. A CIMMINO Genetic and environmental factors in polymyalgia rheumatica Ann Rheum Dis, October 1, 1997; 56(10): 576 - 577. [Full Text]
|
|